NeoStem
420 Lexington Avenue
Suite 350
New York, New York 10170
Telephone: 1.212.584.4180

Amorcyte Scientific Advisory Board

Andrew-Pecora

Andrew L. Pecora, MD, FACP

Chief Visionary Officer - NeoStem, Chief Medical Officer - Progenitor Cell Therapy, Chief Scientific Officer - Amorcyte, and Director


Eugene_Braunwald

Eugene Braunwald, MD, FRCP

Harvard Medical School, Brigham and Women's Hospital


Bernard_Gersh

Bernard Gersh, MD, ChB, DPhil, FRCP

The Mayo Clinic


Dean J Kereiakes

Dean J. Kereiakes, MD, FACC

The Christ Hospital Heart and Vascular Center


Douglas LMann

Douglas L. Mann, MD, FACC

Washington University School of Medicine


Emerson C Perin

Emerson C. Perin, MD, PhD, FACC

Texas Heart Institute


Bertram Pitt

Bertram Pitt, MD

University of Michigan School of Medicine


Arshed Quyyumi

Arshed Quyyumi, MD, FRCP, FACC

Emory University School of Medicine


Edmund-K-Waller

Edmund K. Waller, MD, PhD, FACP

Emory University School of Medicine


James T Willerson

James T. Willerson, MD

Texas Heart Institute


Joseph CWu

Joseph C. Wu, MD, PhD

Stanford University School of Medicine


NeoStem - Cell Therapy Development - Investors